Literature DB >> 11861400

Human tumor suppressor ARF impedes S-phase progression independent of p53.

Wendell G Yarbrough1, Mika Bessho, Adam Zanation, John E Bisi, Yue Xiong.   

Abstract

Using alternative reading frames, the human ARF-INK4a locus encodes two unrelated proteins that both function in tumor suppression. p16(INK4a) maintains the retinoblastoma protein in its growth-suppressive state through inhibition of cyclin D-dependent kinase activity, whereas ARF binds with MDM2 and stabilizes p53. The majority of the activity of ARF to date is ascribed to its ability to activate p53, resulting in a G(1) cell cycle arrest or apoptosis. We show here that ARF colocalizes with DNA replication protein A (RPA32) and that overexpression of ARF reduces the rate of DNA synthesis resulting in accumulation of an S-phase cell population. Impediment of DNA synthesis by ARF can occur and becomes more evident in the absence of p53. Hence, the biological consequence of ARF induction varies dependent on cellular p53 status, inducing predominantly a G(1) arrest or apoptosis in p53-positive cells or causing S-phase retardation when p53 function is comprised.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861400

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  ARF mutation accelerates pituitary tumor development in Rb+/- mice.

Authors:  Kenneth Y Tsai; David MacPherson; Douglas A Rubinson; Alexander Yu Nikitin; Roderick Bronson; Kim L Mercer; Denise Crowley; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-16       Impact factor: 11.205

2.  Transforming growth factor β1 (TGF-β1) suppresses growth of B-cell lymphoma cells by p14(ARF)-dependent regulation of mutant p53.

Authors:  Gang Chen; Paritosh Ghosh; Thomas O'Farrell; Rachel Munk; Louis J Rezanka; Carl Y Sasaki; Dan L Longo
Journal:  J Biol Chem       Date:  2012-05-23       Impact factor: 5.157

3.  ARF triggers cell G1 arrest by a P53 independent ERK pathway.

Authors:  Hansong Du; Weiqi Yao; Min Fang; Dongcheng Wu
Journal:  Mol Cell Biochem       Date:  2011-06-10       Impact factor: 3.396

4.  Targeting of C-terminal binding protein (CtBP) by ARF results in p53-independent apoptosis.

Authors:  Seema Paliwal; Sandhya Pande; Ramesh C Kovi; Norman E Sharpless; Nabeel Bardeesy; Steven R Grossman
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

5.  Human Kruppel-related 3 (HKR3) is a novel transcription activator of alternate reading frame (ARF) gene.

Authors:  Jae-Hyeon Yoon; Won-Il Choi; Bu-Nam Jeon; Dong-In Koh; Min-Kyeong Kim; Myung-Hwa Kim; Jungho Kim; Sujin Susanne Hur; Kyung-Sup Kim; Man-Wook Hur
Journal:  J Biol Chem       Date:  2014-01-01       Impact factor: 5.157

6.  Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functions.

Authors:  Deborah L Burkhart; Stacey E Wirt; Anne-Flore Zmoos; Michael S Kareta; Julien Sage
Journal:  PLoS Genet       Date:  2010-06-24       Impact factor: 5.917

7.  ARF represses androgen receptor transactivation in prostate cancer.

Authors:  Wenfu Lu; Yingqiu Xie; Yufang Ma; Robert J Matusik; Zhenbang Chen
Journal:  Mol Endocrinol       Date:  2013-02-28

8.  p19ARF determines the balance between normal cell proliferation rate and apoptosis during mammary gland development.

Authors:  Yijun Yi; Anne Shepard; Frances Kittrell; Biserka Mulac-Jericevic; Daniel Medina; Thenaa K Said
Journal:  Mol Biol Cell       Date:  2004-05       Impact factor: 4.138

9.  Mitochondrial p32 is a critical mediator of ARF-induced apoptosis.

Authors:  Koji Itahana; Yanping Zhang
Journal:  Cancer Cell       Date:  2008-06       Impact factor: 31.743

10.  p16(Ink4a) interferes with Abelson virus transformation by enhancing apoptosis.

Authors:  Zohar Sachs; Norman E Sharpless; Ronald A DePinho; Naomi Rosenberg
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.